Search results
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoHONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a registrational Phase III clinical trial of HMPL-306
Moleculin Announces U.S. Patent Issue Notification for Lipid-Based Delivery Technology for Annamycin
NBC 17 Raleigh· 6 days agoMoleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Opinion | Ending Oncology's Toxic Relationship With High Chemotherapy Doses
MedPage Today· 5 days agoMany years ago, my patient, a woman in her fifties with chronic myeloid leukemia (CML), got her...
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Morningstar· 6 days agoKite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma ...
Molecular subgroups of T-cell acute lymphoblastic leukemia in adults treated according to...
Nature· 1 day agoIn contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are less well defined in T-lineage ALL. Comprehensive studies on molecular T-ALL subgroups have been predominantly ...
Exxon hit with $725.5 million verdict over mechanic's leukemia diagnosis
Reuters· 5 days ago, opens new tab to pay $725.5 million to a former mechanic who claimed toxic chemicals in the...
ExxonMobil Hit with $725M Verdict for Failure to Warn About Cancer-Causing Benzene in Gasoline
Morningstar· 5 days agoA Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum ...
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...
Nature· 6 days agoT cells are important for the control of acute myeloid leukemia (AML), a common and often deadly malignancy. We observed that some AML ...
Precigen Reports First Quarter 2024 Financial Results and Business Updates
Morningstar· 16 hours ago– Pivotal Phase 2 study data of PRGN-2012 for the treatment of patients with recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation on June 3rd – – Company to host a conference
Tharini Nagarkar, Connor Raine are Ideal Bonaventure Students for 2024
Olean Times Herald· 3 days agoTharini Nagarkar, a health and society major from Danville, California, and Connor Raine, a sports...
